271 related articles for article (PubMed ID: 33054823)
1. Articular involvement, steroid treatment and fibromyalgia are the main determinants of patient-physician discordance in systemic lupus erythematosus.
Elefante E; Tani C; Stagnaro C; Signorini V; Parma A; Carli L; Zucchi D; Ferro F; Mosca M
Arthritis Res Ther; 2020 Oct; 22(1):241. PubMed ID: 33054823
[TBL] [Abstract][Full Text] [Related]
2. Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus.
Elefante E; Tani C; Stagnaro C; Ferro F; Parma A; Carli L; Signorini V; Zucchi D; Peta U; Santoni A; Raffaelli L; Mosca M
RMD Open; 2020 Feb; 6(1):. PubMed ID: 32075876
[TBL] [Abstract][Full Text] [Related]
3. Self-Reported Anxiety and Depression in a Monocentric Cohort of Patients With Systemic Lupus Erythematosus: Analysis of Prevalence, Main Determinants, and Impact on Quality of Life.
Elefante E; Tani C; Stagnaro C; Signorini V; Lenzi B; Zucchi D; Trentin F; Carli L; Ferro F; Mosca M
Front Med (Lausanne); 2022; 9():859840. PubMed ID: 35425779
[TBL] [Abstract][Full Text] [Related]
4. Lupus low disease activity state is associated with a decrease in damage progression in Caucasian patients with SLE, but overlaps with remission.
Zen M; Iaccarino L; Gatto M; Saccon F; Larosa M; Ghirardello A; Punzi L; Doria A
Ann Rheum Dis; 2018 Jan; 77(1):104-110. PubMed ID: 28970217
[TBL] [Abstract][Full Text] [Related]
5. Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study.
Cho J; Shen L; Huq M; Kandane-Rathnayake R; Golder V; Louthrenoo W; Chen YH; Hamijoyo L; Luo SF; Wu YJ; Zamora L; Li Z; Sockalingam S; Katsumata Y; Harigai M; Hao Y; Zhang Z; Basnayake D; Chan M; Kikuchi J; Takeuchi T; Bae SC; Oon S; O'Neill S; Goldblatt F; Ng KPL; Law A; Tugnet N; Kumar S; Tee C; Tee M; Ohkubo N; Tanaka Y; Navarra SV; Lau CS; Hoi A; Morand EF; Nikpour M; Lateef A;
Lancet Rheumatol; 2023 Oct; 5(10):e584-e593. PubMed ID: 38251484
[TBL] [Abstract][Full Text] [Related]
6. Validity of systemic lupus erythematosus disease activity score (SLE-DAS) for definition of lupus low disease activity state (LLDAS).
Abdelhady EI; Rabie M; Hassan RA
Clin Rheumatol; 2021 Nov; 40(11):4553-4558. PubMed ID: 34142298
[TBL] [Abstract][Full Text] [Related]
7. Using Clinical Characteristics and Patient-Reported Outcome Measures to Categorize Systemic Lupus Erythematosus Subtypes.
Rogers JL; Eudy AM; Pisetsky D; Criscione-Schreiber LG; Sun K; Doss J; Clowse MEB
Arthritis Care Res (Hoboken); 2021 Mar; 73(3):386-393. PubMed ID: 31909888
[TBL] [Abstract][Full Text] [Related]
8. Definition and initial validation of a Lupus Low Disease Activity State (LLDAS).
Franklyn K; Lau CS; Navarra SV; Louthrenoo W; Lateef A; Hamijoyo L; Wahono CS; Chen SL; Jin O; Morton S; Hoi A; Huq M; Nikpour M; Morand EF;
Ann Rheum Dis; 2016 Sep; 75(9):1615-21. PubMed ID: 26458737
[TBL] [Abstract][Full Text] [Related]
9. Impact of remission and low disease activity on health-related quality of life in patients with systemic lupus erythematosus.
Emamikia S; Oon S; Gomez A; Lindblom J; Borg A; Enman Y; Morand E; Grannas D; van Vollenhoven RF; Nikpour M; Parodis I
Rheumatology (Oxford); 2022 Nov; 61(12):4752-4762. PubMed ID: 35302581
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of achieving lupus low disease activity state and damage accrual in childhood-onset systemic lupus erythematosus.
Na Nakorn K; Piyaphanee N; Sukharomana M; Pinpatanapong R; Charuvanij S
Clin Rheumatol; 2023 Jun; 42(6):1655-1664. PubMed ID: 36780064
[TBL] [Abstract][Full Text] [Related]
11. Remission and low disease activity in Polish patients with systemic lupus erythematosus - real-life, five-year follow-up outcomes.
Pawlak-Buś K; Schmidt W; Leszczyński P
Eur Rev Med Pharmacol Sci; 2023 Feb; 27(3):949-959. PubMed ID: 36808341
[TBL] [Abstract][Full Text] [Related]
12. Does expert opinion match the definition of lupus low disease activity state? Prospective analysis of 500 patients from a Spanish multicentre cohort.
Altabás-González I; Rúa-Figueroa I; Rubiño F; Mouriño Rodríguez C; Hernández-Rodríguez I; Menor Almagro R; Uriarte Isacelaya E; Tomero Muriel E; Salman-Monte TC; Carrión-Barberà I; Galindo M; Rodríguez Almaraz EM; Jiménez N; Inês L; Pego-Reigosa JM
Rheumatology (Oxford); 2023 Mar; 62(3):1162-1169. PubMed ID: 35961050
[TBL] [Abstract][Full Text] [Related]
13. LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population: data from the Almenara Lupus Cohort.
Ugarte-Gil MF; Gamboa-Cardenas RV; Reátegui-Sokolova C; Pimentel-Quiroz VR; Medina M; Elera-Fitzcarrald C; Zevallos F; Pastor-Asurza CA; Lofland J; Zazzetti F; Karyekar CS; Alarcón GS; Perich-Campos RA
Lupus Sci Med; 2022 Feb; 9(1):. PubMed ID: 35193948
[TBL] [Abstract][Full Text] [Related]
14. Performance of SLE responder index and lupus low disease activity state in real life: A prospective cohort study.
Ramirez GA; Canti V; Moiola L; Magnoni M; Rovere-Querini P; Coletto LA; Dagna L; Manfredi AA; Bozzolo EP
Int J Rheum Dis; 2019 Sep; 22(9):1752-1761. PubMed ID: 31379114
[TBL] [Abstract][Full Text] [Related]
15. Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study.
Golder V; Kandane-Rathnayake R; Hoi AY; Huq M; Louthrenoo W; An Y; Li ZG; Luo SF; Sockalingam S; Lau CS; Mok MY; Lateef A; Franklyn K; Morton S; Navarra ST; Zamora L; Wu YJ; Hamijoyo L; Chan M; O'Neill S; Goldblatt F; Nikpour M; Morand EF;
Arthritis Res Ther; 2017 Mar; 19(1):62. PubMed ID: 28320433
[TBL] [Abstract][Full Text] [Related]
16. Lupus Low Disease Activity State and organ damage in relation to quality of life in systemic lupus erythematosus: a cohort study with up to 11 years of follow-up.
Parodis I; Stephens T; Dominicus A; Eek D; Sjöwall C
Rheumatology (Oxford); 2024 Feb; ():. PubMed ID: 38402496
[TBL] [Abstract][Full Text] [Related]
17. Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus.
Piga M; Floris A; Cappellazzo G; Chessa E; Congia M; Mathieu A; Cauli A
Arthritis Res Ther; 2017 Nov; 19(1):247. PubMed ID: 29126432
[TBL] [Abstract][Full Text] [Related]
18. Lupus low disease activity state within 12 months is associated with favourable outcomes in severely active systemic lupus erythematosus.
Kikuchi J; Hanaoka H; Saito S; Oshige T; Hiramoto K; Kaneko Y; Takeuchi T
Rheumatology (Oxford); 2022 Aug; 61(9):3777-3791. PubMed ID: 35015824
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life, remission and low lupus disease activity state in patients with systemic lupus erythematosus.
Thibault T; Rajillah A; Bourredjem A; Corneloup M; Maurier F; Wahl D; Muller G; Aumaitre O; Sève P; Blaison G; Besancenot JF; Martin T; Magy-Bertrand N; Samson M; Arnaud L; Amoura Z; Devilliers H;
Rheumatology (Oxford); 2024 May; 63(5):1447-1455. PubMed ID: 37589711
[TBL] [Abstract][Full Text] [Related]
20. Does expert opinion match the operational definition of the Lupus Low Disease Activity State (LLDAS)? A case-based construct validity study.
Golder V; Huq M; Franklyn K; Calderone A; Lateef A; Lau CS; Lee ALH; Navarra STV; Godfrey T; Oon S; Hoi AYB; Morand EF; Nikpour M
Semin Arthritis Rheum; 2017 Jun; 46(6):798-803. PubMed ID: 28216192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
